These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
586 related articles for article (PubMed ID: 9654169)
1. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination. Josefsson A; Molander E; Selbing A Acta Obstet Gynecol Scand; 1998 May; 77(5):497-9. PubMed ID: 9654169 [TBL] [Abstract][Full Text] [Related]
2. Diagnosis and management of fetal nuchal translucency. Jackson M; Rose NC Semin Roentgenol; 1998 Oct; 33(4):333-8. PubMed ID: 9800243 [TBL] [Abstract][Full Text] [Related]
3. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. Nicolaides KH; Azar G; Byrne D; Mansur C; Marks K BMJ; 1992 Apr; 304(6831):867-9. PubMed ID: 1392745 [TBL] [Abstract][Full Text] [Related]
5. First-trimester nuchal translucency: a risk analysis on fetal chromosome abnormality. van Vugt JM; van Zalen-Sprock RM; Kostense PJ Radiology; 1996 Aug; 200(2):537-40. PubMed ID: 8685353 [TBL] [Abstract][Full Text] [Related]
6. Ultrasonographic markers for chromosomal abnormalities in women with negative nuchal translucency and second trimester maternal serum biochemistry. Verdin SM; Whitlow BJ; Lazanakis M; Kadir RA; Chatzipapas I; Economides DL Ultrasound Obstet Gynecol; 2000 Oct; 16(5):402-6. PubMed ID: 11169322 [TBL] [Abstract][Full Text] [Related]
7. [Outcome of fetuses with malformations discovered before 14 weeks. Where the discovery is revealed by echography during the first trimester, is it responsible for the voluntary termination of the pregnancy? Comparison before and after July 2001]. Mangione R; Fries N; Godard P; Fontanges M; Haddad G; Mirlesse V; J Gynecol Obstet Biol Reprod (Paris); 2008 Apr; 37(2):154-62. PubMed ID: 18036748 [TBL] [Abstract][Full Text] [Related]
8. The significance of anterolateral neck cysts in early diagnosis of fetal malformations. Meyberg-Solomayer G; Hamza A; Takacs Z; Leingartner A; Radosa J; Joukhadar R; Juhasz-Böss I; Solomayer EF Prenat Diagn; 2016 Apr; 36(4):332-7. PubMed ID: 26847019 [TBL] [Abstract][Full Text] [Related]
9. Screening for chromosomal abnormalities in an unselected population by fetal nuchal translucency. Hafner E; Schuchter K; Philipp K Ultrasound Obstet Gynecol; 1995 Nov; 6(5):330-3. PubMed ID: 8590203 [TBL] [Abstract][Full Text] [Related]
10. Predictive value of increased nuchal translucency as a screening test for the detection of fetal chromosomal abnormalities. Alexioy E; Alexioy E; Trakakis E; Kassanos D; Farmakidis G; Kondylios A; Laggas D; Salamalekis E; Florentin L; Kanavakis E; Basios G; Trompoukis P; Georgiadoy L; Panagiotopoulos T J Matern Fetal Neonatal Med; 2009 Oct; 22(10):857-62. PubMed ID: 19521928 [TBL] [Abstract][Full Text] [Related]
11. Screening for fetal anomalies by ultrasound at 14 and 21 weeks. D'Ottavio G; Meir YJ; Rustico MA; Pecile V; Fischer-Tamaro L; Conoscenti G; Natale R; Mandruzzato GP Ultrasound Obstet Gynecol; 1997 Dec; 10(6):375-80. PubMed ID: 9476319 [TBL] [Abstract][Full Text] [Related]
13. Increased nuchal translucency as a marker for fetal chromosomal defects. Taipale P; Hiilesmaa V; Salonen R; Ylöstalo P N Engl J Med; 1997 Dec; 337(23):1654-8. PubMed ID: 9385124 [TBL] [Abstract][Full Text] [Related]
14. The application of three-dimensional ultrasound to nuchal translucency measurement in early pregnancy (10-14 weeks): a preliminary study. Chung BL; Kim HJ; Lee KH Ultrasound Obstet Gynecol; 2000 Feb; 15(2):122-5. PubMed ID: 10775994 [TBL] [Abstract][Full Text] [Related]
15. [Increased nuchal translucency and cystic hygroma in the first trimester: prenatal diagnosis and neonatal outcome]. Ducarme G; Graesslin O; Alanio E; Bige V; Gaillard D; Gabriel R Gynecol Obstet Fertil; 2005 Oct; 33(10):750-4. PubMed ID: 16139544 [TBL] [Abstract][Full Text] [Related]
16. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population. Schwärzler P; Carvalho JS; Senat MV; Masroor T; Campbell S; Ville Y Br J Obstet Gynaecol; 1999 Oct; 106(10):1029-34. PubMed ID: 10519427 [TBL] [Abstract][Full Text] [Related]
17. Comparison between two- and three-dimensional ultrasound measurements of nuchal translucency. Clementschitsch G; Hasenöhrl G; Schaffer H; Steiner H Ultrasound Obstet Gynecol; 2001 Nov; 18(5):475-80. PubMed ID: 11844167 [TBL] [Abstract][Full Text] [Related]
18. The implementation of first-trimester scanning at 10-13 weeks' gestation and the measurement of fetal nuchal translucency thickness in two maternity units. Pandya PP; Goldberg H; Walton B; Riddle A; Shelley S; Snijders RJ; Nicolaides KH Ultrasound Obstet Gynecol; 1995 Jan; 5(1):20-5. PubMed ID: 7850584 [TBL] [Abstract][Full Text] [Related]
19. Nuchal translucency and the acceptance of invasive prenatal chromosomal diagnosis in women aged 35 and older. Zoppi MA; Ibba RM; Putzolu M; Floris M; Monni G Obstet Gynecol; 2001 Jun; 97(6):916-20. PubMed ID: 11384696 [TBL] [Abstract][Full Text] [Related]
20. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance. Bilardo CM; Müller MA; Pajkrt E; Clur SA; van Zalen MM; Bijlsma EK Ultrasound Obstet Gynecol; 2007 Jul; 30(1):11-8. PubMed ID: 17559183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]